FLT3-ITD mutation + FLT3 D835
|
AML
|
FLT3-ITD mutation + FLT3 D835
|
AML
|
gilteritinib Sensitive: C3 – Early Trials
|
gilteritinib Sensitive: C3 – Early Trials
|
FLT3-ITD mutation + FLT3 D835
|
AML
|
FLT3-ITD mutation + FLT3 D835
|
AML
|
CPI-0610 Sensitive: D – Preclinical
|
CPI-0610 Sensitive: D – Preclinical
|
FLT3-ITD mutation + FLT3 D835
|
AML
|
FLT3-ITD mutation + FLT3 D835
|
AML
|
venetoclax + gilteritinib Sensitive: D – Preclinical
|
venetoclax + gilteritinib Sensitive: D – Preclinical
|